New respiratory syncytial virus immunization products in low- and middle-income countries: potential for cost-effective impact on a high burden of disease in young infants

Autor:	Padmini Srikantiah, Keith P. Klugman
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	Respiratory syncytial virus Maternal vaccine Infant monoclonal antibody Burden Cost effectiveness Low- and middle-income countries Medicine
Zdroj:	BMC Medicine, Vol 21, Iss 1, Pp 1-3 (2023)
Druh dokumentu:	article
ISSN:	1741-7015
DOI:	10.1186/s12916-023-02883-x
Popis:	Abstract As new, efficacious respiratory syncytial virus (RSV) immunization products reach the market, affordable pricing as well as improved estimation of disease burden and the full potential and cost effectiveness of RSV prevention in the hardest hit geographies in low- and middle-income countries are critical to inform country adoption and enable maximum impact against infant disease and mortality globally. The data reported in the special issue underscore the enormous burden, and associated cost, of RSV disease in young infants in several LMICs, including Kenya and South Africa, as well as the potential for RSV maternal vaccines or long-acting monoclonal antibodies, to be cost-effective and possibly even cost-saving.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/6f81a528883f471fa8c96c5a7373569f Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.